₹ 306.55
-2.20 (-0.71%)
M
Marksans Pharma
₹ 306.55
Marksans Pharma EPS Summary (consolidated)
The latest quarterly EPS of Marksans Pharma as of Q2 Sep 2026 stands at ₹3.12. This is a 10.09% fall quarter on quarter and 43.78% growth same quarter last year. For the FY2026 the EPS of Marksans Pharma stands at ₹9.22. This is a 9.76% growth compared with FY2025.
Marksans Pharma EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

